TY - JOUR AU - Bhamidimarri, Kalyan Ram PY - 2016 TI - Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4–5 chronic kidney disease JF - Annals of Translational Medicine; Vol 4, Supplement 1 (October 31, 2016): Annals of Translational Medicine Y2 - 2016 KW - N2 - The prevalence of Hepatitis C (HCV) in patients with advanced renal disease and dialysis is higher than that of general population with rates around 5–10% in Europe and USA (1,2). UR - https://atm.amegroups.org/article/view/12204